Literature DB >> 12471099

Cutting edge: selection of B lymphocyte subsets is regulated by natural IgM.

Nicole Baker1, Michael R Ehrenstein.   

Abstract

Natural IgM has a wide range of actions in the immune system. Here we demonstrate that mice lacking serum IgM have an expansion in splenic marginal zone B cells with a proportionately smaller reduction in follicular B cells. The increase in the marginal zone-follicular B cell ratio (and an expansion in peritoneal B1a cells) is fully reversed by administration of polyclonal IgM, but not by two IgM monoclonals. Mice engineered to have a secreted oligoclonal IgM repertoire with an endogenous membrane IgM also exhibited a similar expansion of marginal zone B cells. We propose that natural IgM, by virtue of its polyreactivity, enhances Ag-driven signaling through the B cell receptor and promotes the formation of follicular B cells. These results demonstrate that natural IgM regulates the selection of B lymphocyte subsets.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12471099     DOI: 10.4049/jimmunol.169.12.6686

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Asbestos activates CH12.LX B-lymphocytes via macrophage signaling.

Authors:  Devon L Rasmussen; Jean C Pfau
Journal:  J Immunotoxicol       Date:  2011-12-01       Impact factor: 3.000

Review 2.  Natural IgM in immune equilibrium and harnessing their therapeutic potential.

Authors:  Srini V Kaveri; Gregg J Silverman; Jagadeesh Bayry
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

Review 3.  The importance of natural IgM: scavenger, protector and regulator.

Authors:  Michael R Ehrenstein; Clare A Notley
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

Review 4.  Natural serum IgM maintains immunological homeostasis and prevents autoimmunity.

Authors:  Jessica J Manson; Claudia Mauri; Michael R Ehrenstein
Journal:  Springer Semin Immunopathol       Date:  2004-12-21

5.  IgM-enriched human intravenous immunoglobulin suppresses T lymphocyte functions in vitro and delays the activation of T lymphocytes in hu-SCID mice.

Authors:  T Vassilev; N Mihaylova; E Voynova; M Nikolova; M Kazatchkine; S Kaveri
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

Review 6.  Selective IgM Deficiency: Clinical and Laboratory Features of 17 Patients and a Review of the Literature.

Authors:  Zita Chovancova; Pavlina Kralickova; Alena Pejchalova; Marketa Bloomfield; Jana Nechvatalova; Marcela Vlkova; Jiri Litzman
Journal:  J Clin Immunol       Date:  2017-07-21       Impact factor: 8.317

7.  Requirement for complement in antibody responses is not explained by the classic pathway activator IgM.

Authors:  Christian Rutemark; Elisabeth Alicot; Anna Bergman; Minghe Ma; Andrew Getahun; Stephan Ellmerich; Michael C Carroll; Birgitta Heyman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

8.  Healthy Donor Polyclonal IgMs Diminish B-Lymphocyte Autoreactivity, Enhance Regulatory T-Cell Generation, and Reverse Type 1 Diabetes in NOD Mice.

Authors:  Christopher S Wilson; Preeti Chhabra; Andrew F Marshall; Caleigh V Morr; Blair T Stocks; Emilee M Hoopes; Rachel H Bonami; Greg Poffenberger; Kenneth L Brayman; Daniel J Moore
Journal:  Diabetes       Date:  2018-08-21       Impact factor: 9.461

9.  Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease.

Authors:  H E Baxendale; M Johnson; R C M Stephens; J Yuste; N Klein; J S Brown; D Goldblatt
Journal:  Clin Exp Immunol       Date:  2007-11-05       Impact factor: 4.330

10.  Enhanced auto-antibody production and Mott cell formation in FcμR-deficient autoimmune mice.

Authors:  Kazuhito Honjo; Yoshiki Kubagawa; Yusuke Suzuki; Miyuki Takagi; Hiroshi Ohno; R Pat Bucy; Shozo Izui; Hiromi Kubagawa
Journal:  Int Immunol       Date:  2014-07-03       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.